| Sam's Pharmacy 10-6379 | |
| 401 Northwest Byp, Great Falls, Montana 59404 | |
| (406) 453-3466 |
| Name | Sam's Pharmacy 10-6379 |
|---|---|
| Organization Name | Sam's West Inc |
| Location | 401 Northwest Byp, Great Falls, Montana 59404 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (406) 453-3466 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Memorial Sloan-Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features such as embargoed content for registered users and "trending topics" - a continually updated listing of story ideas and available experts to comment on the latest health news headlines.
GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's Respiratory Syncytial Virus (RSV) vaccine program.
Professor and director of the WHO Collaborating Centre for Obesity Prevention at Deakin University in Australia, examines how "rich countries, ... particularly the U.S. and European Union but also Australia, Canada and New Zealand, ... are joining forces with tobacco, food, alcohol and pharmaceutical corporations to water down commitments that might flow from" this month's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York.
Amakem NV, a kinase platform company focusing on ophthalmology, presented key preclinical data on its potent, locally active Rho Kinase (ROCK) inhibitor AMA0076 at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held at Fort Lauderdale, US from 6 - 10 May. The ARVO meeting is the world's largest gathering of international eye and vision researchers.
› Verified 3 days ago
| NPI Number | 1124045463 |
| Organization Name | SAMS WEST INC |
| Doing Business As | SAMS PHARMACY 10-6379 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 401 Northwest Byp, Great Falls, MT 59404 |
| Phone Number | 406-453-3466 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Memorial Sloan-Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features such as embargoed content for registered users and "trending topics" - a continually updated listing of story ideas and available experts to comment on the latest health news headlines.
GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's Respiratory Syncytial Virus (RSV) vaccine program.
Professor and director of the WHO Collaborating Centre for Obesity Prevention at Deakin University in Australia, examines how "rich countries, ... particularly the U.S. and European Union but also Australia, Canada and New Zealand, ... are joining forces with tobacco, food, alcohol and pharmaceutical corporations to water down commitments that might flow from" this month's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York.
Amakem NV, a kinase platform company focusing on ophthalmology, presented key preclinical data on its potent, locally active Rho Kinase (ROCK) inhibitor AMA0076 at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held at Fort Lauderdale, US from 6 - 10 May. The ARVO meeting is the world's largest gathering of international eye and vision researchers.
› Verified 3 days ago
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Memorial Sloan-Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features such as embargoed content for registered users and "trending topics" - a continually updated listing of story ideas and available experts to comment on the latest health news headlines.
GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's Respiratory Syncytial Virus (RSV) vaccine program.
Professor and director of the WHO Collaborating Centre for Obesity Prevention at Deakin University in Australia, examines how "rich countries, ... particularly the U.S. and European Union but also Australia, Canada and New Zealand, ... are joining forces with tobacco, food, alcohol and pharmaceutical corporations to water down commitments that might flow from" this month's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York.
Amakem NV, a kinase platform company focusing on ophthalmology, presented key preclinical data on its potent, locally active Rho Kinase (ROCK) inhibitor AMA0076 at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held at Fort Lauderdale, US from 6 - 10 May. The ARVO meeting is the world's largest gathering of international eye and vision researchers.
› Verified 3 days ago
Cvs Pharmacy 08624 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2001 10th Ave S, Great Falls, Montana 59405 Phone: (406) 453-1318 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1302 13th Ave S, Great Falls, Montana 59405 Phone: (406) 771-6668 | |
Wal-mart Pharmacy 10-2455 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 701 Smelter Ave Ne, Great Falls, Montana 59404 Phone: (406) 761-1456 | |
Osco Pharmacy #0035 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1414 3rd St Nw, Great Falls, Montana 59404 Phone: (406) 761-8420 | |
Osco Pharmacy #0037 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2250 10th Ave S, Great Falls, Montana 59405 Phone: (406) 727-9880 |